SFL - 2016 Annual Results
The financial statements for the year ended 31 December 2016 were
approved by the Board of Directors of Société Foncière Lyonnaise
(Paris:FLY) on 10 February 2017 at a meeting chaired by Juan-José
These financial statements show a very sharp rise in all of SFL's business indicators to a historic high, accompanied by further growth in the portfolio's appraisal value and the Company's net asset value.
The auditors have completed their audit of the annual financial information and are in the process of issuing their report.
|Consolidated data (€ millions)|
|Operating profit before disposals and fair value adjustments||169.7||135.3||+25.4%|
|Attributable net profit||504.1||492.9||n.m.|
|Consolidated portfolio value excluding transfer costs||5,736||5,242||+9.4%|
|Consolidated portfolio value including transfer costs||6,092||5,519||+10.4%|
|EPRA NNNAV per share||€66.2||€58.5|
Results: business indicators at a historic high
Rental income stood at €198.1 million in 2016 versus €168.8 million
the year before, an increase of €29.3 million (up 17.4%):
- On a comparable portfolio basis, rental income rose by €10.8 million (up 7.1%), reflecting the lease on the In/Out building which came into effect on 1 September 2015 and various other new leases signed in 2015 and 2016, including at Washington Plaza.
- Rental income from properties that were undergoing renovation in the comparable period was €14.7 million higher, corresponding mainly to rent on the #cloud.paris building delivered in November 2015 and fully let.
- The acquisition of the Percier building in June 2015 generated a €0.6-million increase in rental income in 2016.
- In addition, 2016 rental income was boosted by a €3.2-million lease termination penalties paid notably by a former tenant of the 103 Grenelle building.
- This increase in rental income combined with a €3.7-million reduction in property expenses not recovered from tenants helped to drive a 25.4% increase in operating profit before disposal gains and losses and fair value adjustments to investment properties to €169.7 million in 2016 from €135.3 million in 2015.
- The portfolio's appraisal value grew by 9.4% over the year on a comparable basis. The increase led to the recognition of positive fair value adjustments to investment properties of €438.0 million in 2016 (versus €513.7 million in 2015).
- Net finance costs amounted to €48.1 million in 2016 versus €69.6 million the year before. Non-recurring finance costs represented just €2.1 million in 2016, compared with the previous year's €22.3 million which included bond retirement costs. Recurring finance costs were down by €1.3 million in 2016, due to a reduction in the average cost of debt which offset the effect of higher total borrowings.
- After taking into account these key items, attributable net profit for the year came to €504.1 million versus €492.9 million in 2015. Excluding the impact of disposals, changes in the fair value of investment properties and financial instruments and the related tax effect, EPRA earnings rose by €35.1 million (up 53.3%) to €100.9 million in 2016 from €65.8 million in 2015.
Business review: very high occupancy rate
In a growing but still selective rental market, SFL signed leases on some 34,000 sq.m. in 2016. Highlights of the year included:
- Completion of the #cloud.paris marketing programme, with the signature of a lease with Coty on nearly 3,000 sq.m. in March ;
- Signature of a lease with Quartus on 2,600 sq.m. in the Cézanne Saint-Honoré complex ;
- Marketing of 9,400 sq.m. in the Washington Plaza complex to various tenants ;
- Marketing of 4,300 sq.m. in the 103 Grenelle complex to various tenants ;
- Marketing of some 2,100 sq.m. in the fully renovated Percier building.
The average nominal rent for these office leases stands at €631 per sq.m. and the effective rent at €548 per sq.m.
The physical occupancy rate for revenue-generating properties at 31 December 2016 was 97.0%, compared with 95.6% at the previous year end. Over the same period, the EPRA vacancy rate decreased to 3.1% from 5.1%.
Capital expenditure in 2016 amounted to €66 million and corresponded to the remaining work on major development projects that have now been completed, including the upgrading of the common areas in the Cézanne Saint-Honoré complex and the renovation of the Percier building acquired in June 2015.
The development pipeline at 31 December 2016 concerned approximately 6% of the Group's portfolio and mainly consisted of the retail units in the Louvre Saint-Honoré complex for which the planning approval process is in its final stages.
In June 2016, SFL exercised its option to acquire the 131 Wagram building upon expiry of the finance lease.
No properties were sold in 2016.
On 13 January 2017, SFL entered into a €165-million deal to acquire SMA's historical headquarters building, a 21,000-sq.m. property located in the 15th arrondissement of Paris that the Company intends to redevelop. Contracts will be exchanged when SMA moves to its new headquarters in the fourth quarter of 2017 (for more details, see press release dated 16 January 2017).
Financing: historically low average borrowing costs
Net debt at 31 December 2016 amounted to €1,931 million (compared with €1,841 million at 31 December 2015), representing a loan-to-value ratio of 31.7%. At that date, the average cost of debt after hedging was 1.9% (versus 2.4% a year earlier) and the average maturity was 4.4 years.
In May 2016, SFL obtained a new €150-million 5-year revolving credit facility from BNP Paribas.
At 31 December 2016, the Company also had €540 million in undrawn back-up lines of credit.
Net Asset Value
The consolidated market value of the portfolio at 31 December 2016 was €5,736 million excluding transfer costs. The increase of 9.4% from €5,242 million at 31 December 2015 reflected the increasingly narrow yields that were a feature of the Paris property market during 2016 and the resilience of the portfolio's rental values.
The average EPRA topped-up net investment yield (NIY) stood at 3.6% at 31 December 2016, compared with 3.8% at 31 December 2015.
EPRA NNNAV stood at €3,082 million or €66.2 per share at 31 December 2016, an increase of 13.3% compared to €58.5 per share at 31 December 2015.
At the Annual General Meeting to be held on 28 April 2017, the Board of Directors will recommend paying a dividend of €1.05 per share. This will be in addition to the dividend of €1.05 per share paid on 22 November 2016.
Alternative Performance Indicators (APIs)
API EPRA earnings
|Attributable net profit||504.1||492.9|
|Profit (loss) on asset disposals||-||-|
|Fair value adjustments to investment properties||(438.0)||(513.7)|
|Fair value adjustments to financial instruments, discounting adjustments to debt and related costs||2.1||22.3|
|Tax on the above items||(11.6)||25.3|
|Non-controlling interests in the above items||44.3||39.0|
API EPRA NNNAV
|Unrealised capital gains||16||14|
|Fair value adjustments to fixed rate debt||(71)||(23)|
More information is available at www.fonciere-lyonnaise.com
Leader on the prime segment of the Parisian tertiary real estate market, Société Foncière Lyonnaise stands out for the quality of its property portfolio, which is valued at €5.7 billion and is concentrated on the Central Business District of Paris (Louvre Saint-Honoré, Edouard VII, Washington Plaza, etc.), and for the quality of its client portfolio, which is composed of prestigious companies in the consulting, media, digital, luxury, finance and insurance sectors.
Stock market: Euronext Paris Compartment A – Euronext Paris ISIN FR0000033409 – Bloomberg: FLY FP – Reuters: FLYP PA
S&P rating: BBB stable outlook
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28 | Pressemelding
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05 | Pressemelding
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52 | Pressemelding
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00 | Pressemelding
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on